Kerala Ayurveda Intrinsic Value
Kerala Ayurveda (KERALAYUR) median intrinsic value is ₹59.58 from 3 valuation models (range ₹30–₹228), vs current price ₹148.95 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Analyse KERALAYUR promoter holding to track promoter, FII and institutional holdings.
KERALAYUR Valuation Methods Summary — DCF, Graham Number & P/E
Kerala Ayurveda intrinsic value across 3 models vs current price ₹148.95 — upside/downside and value range per method. For current market price and key ratios, visit KERALAYUR screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹29.79 | ₹26.81 - ₹32.77 | -80.0% | Book Value/Share: ₹8.46, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹227.69 | ₹204.92 - ₹250.46 | +52.9% | Revenue/Share: ₹113.85, P/S: 2.0x |
| Simple DCF (5Y) | dcf | ₹59.58 | ₹47.66 - ₹71.50 | -60.0% | CF Growth: 5.0%, Discount: 15% |
KERALAYUR Intrinsic Value vs Market Price — All Valuation Models
Kerala Ayurveda fair value range ₹30–₹228 vs current market price ₹148.95 across 3 valuation models. Read KERALAYUR dividend history for the complete payout history and dividend yield track record.
KERALAYUR Intrinsic Value Analysis — Undervalued or Overvalued?
Kerala Ayurveda median intrinsic value ₹59.58, current price ₹148.95 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.
What is the intrinsic value of KERALAYUR?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Kerala Ayurveda (KERALAYUR) is ₹59.58 (median value). With the current market price of ₹148.95, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹29.79 to ₹227.69, indicating ₹29.79 - ₹227.69.
Is KERALAYUR undervalued or overvalued?
Based on our multi-method analysis, Kerala Ayurveda (KERALAYUR) appears to be trading above calculated value by approximately 60.0%.
KERALAYUR Financial Health — Key Ratios vs Industry Benchmarks
Kerala Ayurveda financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.96 | Industry Standard: 2.0+ | Above 1.5 | Measures short-term liquidity capacity |
| Return on Equity | -254.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -20.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.07x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
KERALAYUR Cash Flow Quality — Operating & Free Cash Flow
Kerala Ayurveda operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹5 Cr | ₹-3 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹10 Cr | ₹7 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹-1 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹7 Cr | ₹7 Cr | Positive Free Cash Flow | 8/10 |